Sabby Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Sabby Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-275	Closed	-$321K	–	346
2016 Q3	$321K	Sell	275 -1,461	-84%	-$17.2K	0.01%	251
2016 Q2	$1.88M	Buy	+1,736	New	+$17.9K	0.1%	112
2015 Q4	–	Sell	-1,000	Closed	-$1.64M	–	396
2015 Q3	$1.64M	Buy	+1,000	New	+$20.5K	0.07%	184
2014 Q2	–	Sell	-1,729	Closed	-$2.01M	–	296
2014 Q1	$2.01M	Sell	1,729 -858	-33%	-$14.5K	0.11%	108
2013 Q4	$4.57M	Buy	2,587 +2,065	+396%	+$34.7K	0.29%	52
2013 Q3	$751K	Hold	522	–	–	0.05%	134
2013 Q2	$786K	Buy	+522	New	+$6.89K	0.05%	131

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sabby Management's MNTA Position: Q3 2016 in Review

Sabby Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2016, closing a stake of 145,600 shares — an estimated $1.71M sold.

Sabby Management first reported a position in MNTA in Q1 2014 and held it in 5 quarters. The position peaked at $2.59M in Q1 2016. 155 funds tracked by Wall St. Rank hold MNTA as of Q3 2016.

Sabby Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
Sabby Management sold 145,600 Momenta Pharmaceuticals, Inc. shares in Q3 2016, an estimated $1.71M.
Sabby Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 5 quarters.
Sabby Management's Momenta Pharmaceuticals, Inc. position peaked at $2.59M in Q1 2016.
155 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2016.

Based on Sabby Management's 13F filing for Q3 2016, filed 14 Nov 2016.